U.S. Pharmacist Weekly News
September 15, 2021

Why More Heart Failure Patients Aren’t Prescribed Sacubitril/Valsartan Combo

Medicare patients are significantly less likely to be prescribed sacubitril/valsartan for heart failure than those with commercial insurance—even though the commercial payors are more likely to require preauthorization. Study authors suggest that the difference was in requirements for patient copayment, which was much more common with Medicare plans. Here are more details.

Advertisement

COVID-19 Is Milder in Children But Still Much Worse
Than Influenza

Children tend to have much milder cases of COVID-19 than adults, but infection with the novel coronavirus isn’t “just like the flu,” as some naysayers have claimed. Find out what differentiates the two viruses and what makes COVID-19 so much worse for children, especially those with preexisting conditions.

Finerenone Reduces CV Issues in T2D Patients With Moderate Kidney Disease

Type 2 diabetes (T2D) patients with chronic kidney disease face increased risks of cardiovascular (CV) events and heart failure. A selective nonsteroidal mineralocorticoid receptor antagonist, finerenone, shows promise in reducing those risks in T2D patients with mild-to-moderate chronic kidney disease. Here is more information. 

Advertisement

Factors Affecting Adherence to Oral Liquid Medications

According to the World Health Organization, patients may not be taking 50% of their medications as prescribed by providers, and this omission of therapy can lead to negative health-related outcomes (including but not limited to treatment failures, hospital admissions, and increased costs). Here are more details.

 
Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -